The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McClellan, S. A.
Right arrow Articles by Hazlett, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McClellan, S. A.
Right arrow Articles by Hazlett, L. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2003, 170: 5219-5227.
Copyright © 2003 by The American Association of Immunologists

Macrophages Restrict Pseudomonas aeruginosa Growth, Regulate Polymorphonuclear Neutrophil Influx, and Balance Pro- and Anti-Inflammatory Cytokines in BALB/c Mice1

Sharon A. McClellan, Xi Huang, Ronald P. Barrett, Nico van Rooijen and Linda D. Hazlett2

Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI 48201; and Department of Cell Biology and Immunology, Free University, Amsterdam, The Netherlands

The role of macrophages in Pseudomonas aeruginosa corneal infection in susceptible (cornea perforates), C57BL/6 (B6) vs resistant (cornea heals), BALB/c mice was tested by depleting macrophages using subconjunctival injections of clodronate-containing liposomes before corneal infection. Both groups of inbred mice treated with clodronate-liposomes compared with PBS-liposomes (controls) exhibited more severe disease. In B6 mice, the cornea perforated and the eye became extremely shrunken, whereas in BALB/c mice, the cornea perforated rather than healed. The myeloperoxidase assay detected significantly more PMN in the cornea of both groups of mice treated with clodronate-liposomes vs PBS-liposomes. In independent experiments, ELISA analysis showed that protein levels for IL-1{beta}, macrophage-inflammatory protein 2, and macrophage-inflammatory protein 1{alpha}, all regulators of PMN chemotaxis, also were elevated in both groups of mice treated with clodronate-liposomes. Bacterial plate counts in B6 mice treated with clodronate-liposomes were unchanged at 3 days and were higher in control-treated mice at 5 days postinfection (p.i.), whereas in BALB/c mice, bacterial load was significantly elevated in the cornea of mice treated with clodronate-liposomes at both 3 and 5 days p.i. mRNA expression levels for pro (IFN-{gamma} and TNF-{alpha})- and anti (IL-4 and IL-10)-inflammatory cytokines also were determined in BALB/c mice treated with clodronate-liposomes vs control-treated mice. Expression levels for IFN-{gamma} were significantly elevated in mice treated with clodronate-liposomes at 3 and 5 days p.i., while IL-10 levels (mRNA and protein) were reduced. These data provide evidence that macrophages control resistance to P. aeruginosa corneal infection through regulation of PMN number, bacterial killing and balancing pro- and anti-inflammatory cytokine levels.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. M. Manicone, T. P. Birkland, M. Lin, T. Betsuyaku, N. van Rooijen, J. Lohi, J. Keski-Oja, Y. Wang, S. J. Skerrett, and W. C. Parks
Epilysin (MMP-28) Restrains Early Macrophage Recruitment in Pseudomonas aeruginosa Pneumonia
J. Immunol., March 15, 2009; 182(6): 3866 - 3876.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Z. Zhou, R. P. Barrett, S. A. McClellan, Y. Zhang, E. A. Szliter, N. van Rooijen, and L. D. Hazlett
Substance P Delays Apoptosis, Enhancing Keratitis after Pseudomonas aeruginosa Infection
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4458 - 4467.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. A. McClellan, Y. Zhang, R. P. Barrett, and L. D. Hazlett
Substance P Promotes Susceptibility to Pseudomonas aeruginosa Keratitis in Resistant Mice: Anti-inflammatory Mediators Downregulated
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1502 - 1511.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. D. Hazlett, Q. Li, J. Liu, S. McClellan, W. Du, and R. P. Barrett
NKT Cells Are Critical to Initiate an Inflammatory Response after Pseudomonas aeruginosa Ocular Infection in Susceptible Mice
J. Immunol., July 15, 2007; 179(2): 1138 - 1146.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. Biteman, I. R. Hassan, E. Walker, A. J. Leedom, M. Dunn, F. Seta, M. Laniado-Schwartzman, and K. Gronert
Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing
FASEB J, July 1, 2007; 21(9): 2257 - 2266.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. D. Hazlett, S. A. McClellan, R. P. Barrett, J. Liu, Y. Zhang, and S. Lighvani
Spantide I Decreases Type I Cytokines, Enhances IL-10, and Reduces Corneal Perforation in Susceptible Mice after Pseudomonas aeruginosa Infection
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 797 - 807.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. A. Szliter, S. Lighvani, R. P. Barrett, and L. D. Hazlett
Vasoactive Intestinal Peptide Balances Pro- and Anti-Inflammatory Cytokines in the Pseudomonas aeruginosa-Infected Cornea and Protects against Corneal Perforation
J. Immunol., January 15, 2007; 178(2): 1105 - 1114.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Huang, R. P. Barrett, S. A. McClellan, and L. D. Hazlett
Silencing Toll-like Receptor-9 in Pseudomonas aeruginosa Keratitis
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4209 - 4216.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
A. Thakur, R. P. Barrett, J. A. Hobden, and L. D. Hazlett
Caspase-1 Inhibitor Reduces Severity of Pseudomonas aeruginosa Keratitis in Mice
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3177 - 3184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.